A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling.
Bone biology is physiologically complex and intimately linked to calcium homeostasis. The literature provides a wealth of qualitative and/or quantitative descriptions of cellular mechanisms, bone dynamics, associated organ dynamics, related disease sequela, and results of therapeutic interventions. We present a physiologically based mathematical model of integrated calcium homeostasis and bone biology constructed from literature data. The model includes relevant cellular aspects with major controlling mechanisms for bone remodeling and calcium homeostasis and appropriately describes a broad range of clinical and therapeutic conditions. These include changes in plasma parathyroid hormone (PTH), calcitriol, calcium and phosphate (PO4), and bone-remodeling markers as manifested by hypoparathyroidism and hyperparathyroidism, renal insufficiency, daily PTH 1-34 administration, and receptor activator of NF-kappaB ligand (RANKL) inhibition. This model highlights the utility of systems approaches to physiologic modeling in the bone field. The presented bone and calcium homeostasis model provides an integrated mathematical construct to conduct hypothesis testing of influential system aspects, to visualize elements of this complex endocrine system, and to continue to build upon iteratively with the results of ongoing scientific research.
Peterson
Mark C
MC
Amgen, Inc., One Amgen Center Drive, MS 28-3-B, Thousand Oaks, CA 91320, USA. mark.peterson@biogenidec.com
Riggs
Matthew M
MM
D016723:Bone Remodeling / Q000502:physiology*; D002117:Calcitriol / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D008954:Models, Biological; D008962:Models, Theoretical; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000378:metabolism
D010281:Parathyroid Hormone; D010710:Phosphates; D002117:Calcitriol; D002118:Calcium